JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial.

about

JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial.

Item

http://www.wikidata.org/entity/Q41332584

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

JinqiJiangtang tablets for pre ...... ebo-controlled clinical trial.

@en

type

Item

label

JinqiJiangtang tablets for pre ...... ebo-controlled clinical trial.

@en

prefLabel

JinqiJiangtang tablets for pre ...... ebo-controlled clinical trial.

@en

P1476

JinqiJiangtang tablets for pre ...... ebo-controlled clinical trial.

@en

P2093

Chen Yao

http://www.w3.org/2001/XMLSchema#string

Chunxiang Liu

http://www.w3.org/2001/XMLSchema#string

Da Huo

http://www.w3.org/2001/XMLSchema#string

Dehui Wang

http://www.w3.org/2001/XMLSchema#string

Hongbo Cao

http://www.w3.org/2001/XMLSchema#string

Hongcai Shang

http://www.w3.org/2001/XMLSchema#string

Hui Wang

http://www.w3.org/2001/XMLSchema#string

Jianzong Chen

http://www.w3.org/2001/XMLSchema#string

Jingbo Zhai

http://www.w3.org/2001/XMLSchema#string

Junhua Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological research

Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis

Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion

Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats

JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial.

Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine.

Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus.

Prediabetes: a high-risk state for diabetes development.

P2888

s41598-017-11583-5

P304

11190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-11583-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28894283

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

5593818

http://www.w3.org/2001/XMLSchema#string